Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
Rank in Stocks #17922
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
Share Price
$18.20
Last synced: 2025-05-09
Market Cap
$220.35M
Change (1 day)
-5.34%
Change (1 year)
0.00%
Country
JP
Trade I'rom Group Co., Ltd. (2372)

Category

Revenue for I'rom Group Co., Ltd. (2372)
Revenue in Dec 2024 TTM: $119.61M
According to I'rom Group Co., Ltd. latest financial reports the company's current revenue (TTM) is $119.61M. In 2023 the company made a revenue of $138.21M an increase over the revenue in the year 2022 that was $128.89M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for I'rom Group Co., Ltd. from 2005 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $119.61M 2.05%
2024 $117.21M -15.20%
2023 $138.21M 7.24%
2022 $128.89M 10.61%
2021 $116.52M 18.27%
2020 $98.53M 3.39%
2019 $95.30M 17.45%
2018 $81.14M 84.82%
2017 $43.90M 20.07%
2016 $36.56M 6.08%
2015 $34.47M -11.37%
2014 $38.89M -45.34%
2013 $71.14M -46.43%
2012 $132.81M -21.31%
2011 $168.78M 14.16%
2010 $147.85M 0.49%
2009 $147.13M 6.89%
2008 $137.65M 9.43%
2007 $125.78M 16.35%
2006 $108.10M 100.44%
2005 $53.93M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$78.01B 65,123.26%
US
- -
DE
$3.89B 3,156.35%
SA
$21.81B 18,136.06%
US
- -
MY